Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 2Phase 1/2 1Phase 1 1

Status

Unknown 2Recruiting 2Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 105OTHER_GOV 6INDUSTRY 6UNKNOWN 1

Study Type

Interventional 6

Sponsor

Cancer Type

Gastrointestinal 6Thoracic 3Gynecologic 1

Conditions

Esophageal Neoplasms 3Stomach Neoplasms 1Esophageal Squamous Cell Carcinoma 1Colorectal Neoplasms 1Adenocarcinoma Of Esophagus 1

Interventions

Oxaliplatin 30Capecitabine 26Fluorouracil 20Irinotecan 19tislelizumab 18apatinib 16Paclitaxel 13Cisplatin 13S 1 (combination) 12Radiotherapy 12Leucovorin 11Bevacizumab 11Laparoscopy 9Drug Therapy 9Cetuximab 9sintilimab 8Endoscopic Mucosal Resection 8Radiation 7Gemcitabine 7Docetaxel 7camrelizumab 6XELOX 6Surgical Procedures, Operative 6Propranolol 6Nivolumab 6Neoadjuvant Therapy 6Immune Checkpoint Inhibitors 6Folfox protocol 6Levoleucovorin 5HMPL-013 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
OTHER_GOV × Immune Checkpoint Inhibitors × Gastrointestinal × Clear all
NCT07034118 2025-06-24

Definitive Proton Radiotherapy Combined With Chemotherapy and Immunotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Phase I Clinical Study

Anhui Provincial Hospital

Phase 1 Not yet recruiting
23 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT05937438 2025-01-29

Postoperative Radiotherapy Followed by Immunotherapy for Locally Advanced Esophageal Carcinoma

Anhui Provincial Hospital

Phase 1/2 Recruiting
70 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT04891900 2024-07-08

TQB2450 Plus Anlotinib Combined With Chemotherapy in the Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma

Henan Cancer Hospital

Phase NA Unknown
25 enrolled
Gastrointestinal

Stomach Neoplasms

NCT06321081 2024-03-20

ICE Study: Combination of Irinotecan Plus Cetuximab and Envafolimab as a Rechallenge Regimen in mCRC

Beijing Hospital

Phase 2 Recruiting
60 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT05007145 2021-12-21

REVO

Fujian Cancer Hospital

Phase 2 Unknown
92 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT05001360 2021-10-27

Study of FMT Combined With Nivolumab in Gastric Cancer

Fujian Cancer Hospital

Phase NA Withdrawn
Gastrointestinal

Adenocarcinoma Of Esophagus

Data powered by HemOnc (CC BY 4.0) Colophon âš¡